World Health Organization Guidelines: Problem Areas in Cancer Pain Management

Ventafridda V. , Caraceni A. , Sbanotto A. . Cancer pain management. Pain Rev. 1996; 3: 153–179.

Cancer Pain Relief and Palliative Care. Geneva, Switzerland: World Health Organization; 1990.

Ventafridda V. , Tamburini M. , Caraceni A. . A validation study of the WHO method for cancer pain relief. Cancer. 1987; 59: 850–856.

Wenk R. , Diaz C. , Echeverria M. . Argentina's WHO Cancer Pain Relief Program: a patient care model. J Pain Symptom Manage. 1991; 6: 40–43.

Zech D.F. , Grond S. , Lynch J. . Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995; 63: 65–76.

Takeda F. . Results of a field-testing in Japan of the WHO draft interim guideline on relief of cancer pain. 1986; 1: 83–89.

Cleeland C.S. , Gonin R. , Hatfield A.K. . Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994; 330: 592–596.

Jadad A.R. , Browman G.P. . The WHO analgesic ladder for cancer pain management: stepping up the quality of its evaluation. JAMA. 1995; 274: 1870–1873.

Eisenberg E. , Berkey C.S. , Carr D.B. . Efficacy and safety of nonsteroidal anti-inflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol. 1994; 12: 2756–2765.

Ashby M.A. , Fleming B.G. , Brooksbank M. . Description of a mechanistic approach to pain management in advanced cancer: preliminary report. Pain. 1992; 51: 153–161.

Mercadante S. . Malignant bone pain: pathophysiology and treatment. Pain. 1997; 69: 1–18.

Mercadante S. , Casuccio A. , Agnello A. . The analgesic effect of non steroidal anti-inflammatory drugs (NSAIDs) in cancer pain due to somatic and visceral mechanism. J Pain Symptom Manage. 1999. In press.

Mercadante S. . Pain treatment and outcome in advanced cancer patients followed at home. Cancer. 1999. In press.

De Conno F. , Caraceni A. , Groff L. . Effect of home care on the place of death of advanced cancer patients. Eur J Cancer. 1996; 32A: 1142–1147.

Schug S.A. , Zech D. , Grond S. . A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage. 1992; 7: 259–266.

Hanks G.W. , De Conno F. , Ripamonti C. . Morphine in cancer pain: modes of administration. Br Med J. 1996; 312: 823–826.

Mercadante S. , Sapio M. , Caligara M. . Opioid-sparing effect of diclofenac in cancer pain. J Pain Symptom Manage. 1997; 14: 15–20.

Mercadante S. , Genovese G. , Kargar J.A. . Home palliative care: results in 1991 versus 1988. J Pain Symptom Manage. 1992; 7: 414–418.

Ventafridda V. , De Conno F. , Panerai A.E. . Non-steroidal anti-inflammatory drugs as the first step in cancer pain therapy: double-blind, within patient study comparing nine drugs. J Int Med Res. 1990; 18: 21–29.

Singh G. , Ramey D.R. , Morfeld D. . Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med. 1996; 156: 1530–1536

Mercadante S. , Salvaggio L. , Dardanoni G. . Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain. J Pain Symptom Manage. 1998; 15: 76–81.

De Conno F. , Ripamonti C. , Sbanotto A. . A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine and pentazocine in cancer pain. J Pain Symptom Manage. 1991; 6: 423–427.

Boisvert M. , Cohen S.R. . Opioid use in advanced malignant disease: why do different centers use vastly different doses? A plea for standardized reporting. J Pain Symptom Manage. 1995; 10: 632–638.

Cherny N.J. , Chang V. , Frager G. . Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer. 1995; 76: 1283–1293.

Mercadante S. . Opioid rotation in cancer pain: rationale and clinical aspects. Cancer. 1999. In press.

Grond S. , Zech D. , Schug S.A. . Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage. 1991; 6: 411–422.

Mercadante S. , Fulfaro F. . Alternative routes to oral morphine in cancer pain. Oncology. 1999. In press.

Ahmedzai S. , Brooks D. . Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage. 1997; 13: 254–261.

The TTS-Fentanyl Multicentre Study Group. Transdermal fentanyl in cancer pain. J Drug Dev. 1994; 6: 93–97.

Mercadante S. . Opioid poorly responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage. 1999. In press.

Mercadante S. . Ketamine in cancer pain: an update. Palliat Med. 1996; 10: 225–230.

Hogan Q. , Haddox J.D. , Abram S. . Epidural opiates and local anesthetics for the management of cancer pain. Pain. 1991; 46: 271–279.

Mercadante S. . Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 1999; 79: 1–13.

Ventafridda V. , Caraceni A. . Cancer pain. In: Raj P.P. . Current review of pain. Current Medicine. Philadelphia, Pa: 1994: 155–178.

Mercadante S. , Salvaggio L. . Cancer pain knowledge in Southern Italy: data from a postgraduate refresher course. J Pain Symptom Manage. 1996; 11: 108–115.

Mercadante S. . Oral morphine consumption in Italy and Sicily. J Pain Symptom Manage. 1998; 15: 227–230.

Zenz M. , Willweber-Strumpf A. . Opiophobia and cancer pain in Europe. Lancet. 1993; 341: 1075–1078.